Roche to Complete $1.5 Billion Acquisition of Poseida Therapeutics
ZURICH – On Wednesday, Roche said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics (NASDAQ: PSTX), […]
Roche to Complete $1.5 Billion Acquisition of Poseida Therapeutics Read More »
